Ethan H Mereish1, Ji Hyun Lee2, Kristi E Gamarel3, Nickolas D Zaller4, Don Operario2. 1. Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Box G-S121-4, Providence RI 02912, USA. Electronic address: ethan_mereish@brown.edu. 2. Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Box G-S121-4, Providence RI 02912, USA. 3. Department of Psychiatry and Human Behavior, Alpert Medical School, Brown University, Providence, RI, USA. 4. Department of Health Behavior and Health Education, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences Little Rock, AR, USA.
Abstract
BACKGROUND AND AIMS: Sexual minority women (SMW) are at greater risk for alcohol use disorders (AUDs) compared to heterosexual women. However, there is a dearth of research on sexual orientation disparities in co-occurring disorders among women with AUDs. We examined disparities in lifetime co-occurring psychiatric and drug use disorders among a nationally representative sample of women with lifetime AUDs. METHODS: Data were analyzed from the 2004-2005 (Wave 2) of the National Epidemiological Survey on Alcohol and Related Conditions (NESARC), which was collected in structured diagnostic face-to-face interviews. Adult women with AUDs (N=4342) were included in the analyses and approximately 191 of those women self-identified as SMW. Lifetime alcohol and drug use disorders and psychiatric disorders were assessed using DSM-IV criteria. We conducted multivariate logistic regression analyses to compare SMW and heterosexual women with lifetime AUDs on lifetime psychiatric disorders and drug use disorders, while adjusting for sociodemographic variables. FINDINGS: While accounting for several covariates, SMW with lifetime AUDs were more likely than heterosexual women with lifetime AUDs to have lifetime psychiatric disorders (e.g., mood, anxiety, panic disorders) and drug use disorders (e.g., prescription drugs, cannabis use disorders). CONCLUSIONS: Sexual minority women with lifetime alcohol use disorders are at heightened risk for co-occurring psychiatric and drug use disorders than heterosexual women with lifetime alcohol use disorders. The findings warrant the need for more research and empirically based interventions for the comprehensive treatment and prevention of alcohol use disorders among sexual minority women.
BACKGROUND AND AIMS: Sexual minority women (SMW) are at greater risk for alcohol use disorders (AUDs) compared to heterosexual women. However, there is a dearth of research on sexual orientation disparities in co-occurring disorders among women with AUDs. We examined disparities in lifetime co-occurring psychiatric and drug use disorders among a nationally representative sample of women with lifetime AUDs. METHODS: Data were analyzed from the 2004-2005 (Wave 2) of the National Epidemiological Survey on Alcohol and Related Conditions (NESARC), which was collected in structured diagnostic face-to-face interviews. Adult women with AUDs (N=4342) were included in the analyses and approximately 191 of those women self-identified as SMW. Lifetime alcohol and drug use disorders and psychiatric disorders were assessed using DSM-IV criteria. We conducted multivariate logistic regression analyses to compare SMW and heterosexual women with lifetime AUDs on lifetime psychiatric disorders and drug use disorders, while adjusting for sociodemographic variables. FINDINGS: While accounting for several covariates, SMW with lifetime AUDs were more likely than heterosexual women with lifetime AUDs to have lifetime psychiatric disorders (e.g., mood, anxiety, panic disorders) and drug use disorders (e.g., prescription drugs, cannabis use disorders). CONCLUSIONS: Sexual minority women with lifetime alcohol use disorders are at heightened risk for co-occurring psychiatric and drug use disorders than heterosexual women with lifetime alcohol use disorders. The findings warrant the need for more research and empirically based interventions for the comprehensive treatment and prevention of alcohol use disorders among sexual minority women.
Authors: Mark S Friedman; Michael P Marshal; Thomas E Guadamuz; Chongyi Wei; Carolyn F Wong; Elizabeth Saewyc; Ron Stall Journal: Am J Public Health Date: 2011-06-16 Impact factor: 9.308
Authors: Tonda L Hughes; Laura A Szalacha; Timothy P Johnson; Kelly E Kinnison; Sharon C Wilsnack; Young Cho Journal: Addict Behav Date: 2010-07-23 Impact factor: 3.913
Authors: Bryan Hartzler; Beatriz H Carlini; Howard Newville; Heidi M Crane; Joseph J Eron; Elvin H Geng; W Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan Journal: AIDS Care Date: 2016-12-23
Authors: Bradley T Kerridge; Roger P Pickering; Tulshi D Saha; W June Ruan; S Patricia Chou; Haitao Zhang; Jeesun Jung; Deborah S Hasin Journal: Drug Alcohol Depend Date: 2016-11-07 Impact factor: 4.492
Authors: Emily C Helminen; Jillian R Scheer; Skyler D Jackson; Cal D Brisbin; Abigail W Batchelder; Cory J Cascalheira; Tami P Sullivan Journal: Behav Med Date: 2021-12-06 Impact factor: 3.879
Authors: Laurie A Drabble; Karen F Trocki; Rachael A Korcha; Jamie L Klinger; Cindy B Veldhuis; Tonda L Hughes Journal: Drug Alcohol Depend Date: 2018-02-21 Impact factor: 4.492
Authors: Jennifer K Felner; Sean J Haley; Hee-Jin Jun; Jennifer P Wisdom; Laura Katuska; Heather L Corliss Journal: Addict Behav Date: 2021-01-07 Impact factor: 3.913
Authors: Robin J Lewis; Kelly A Romano; Sarah J Ehlke; Cathy Lau-Barraco; Cassidy M Sandoval; Douglas J Glenn; Kristin E Heron Journal: Exp Clin Psychopharmacol Date: 2021-06-07 Impact factor: 3.492
Authors: Hee-Jin Jun; Megan Webb-Morgan; Jennifer K Felner; Jennifer P Wisdom; Sean J Haley; S Bryn Austin; Laura M Katuska; Heather L Corliss Journal: Drug Alcohol Depend Date: 2019-10-17 Impact factor: 4.492
Authors: Jeremy D Kidd; Margaret M Paschen-Wolff; Amy A Mericle; Billy A Caceres; Laurie A Drabble; Tonda L Hughes Journal: J Subst Abuse Treat Date: 2021-06-16